Click a topic below for an index of articles:

 

New-Material

Home

Donate

Alternative-Treatments

Financial or Socio-Economic Issues

Forum

Health Insurance

Hepatitis

HIV/AIDS

Institutional Issues

International Reports

Legal Concerns

Math Models or Methods to Predict Trends

Medical Issues

Our Sponsors

Occupational Concerns

Our Board

Projects

Religion and infectious diseases

State Governments

Stigma or Discrimination Issues

If you would like to submit an article to this website, email us at info@heart-intl.net for a review of this paper
info@heart-intl.net

 

 

 

any words all words
Results per page:

“The only thing necessary for these diseases to the triumph is for good people and governments to do nothing.”

  


     


Healthcare Cost of Hepatitis C-infected Members in a Managed Care
Organization.


This article appeared in the December Health Policy Our Sponsors from
Thomas Jefferson University's Medical College.   The MCO studied was a
73,869 member medicaid MCO.    The data presented includes:

From a cohort of 73,869 medicaid MCO members studied, 395 (0.535%)
met the inclusion criteria for Hepatitis C Virus.  The mean age was 46.5 years.   The 395
members had medical claims totaling $4,075.082.  Inpatient hospital services
accounted for 48% of these costs.  Further analysis showed that patients
with a history of transplant or transplant procedure (=12) performed in 1999
had medical claims totaling $600,445.  Inpatient claims for this group
accounted for $497,594 of the total medical claims.  In addition, there was
a significant patient outlier that had total medical costs of $881.933.  The
majority of these costs were related to home care.   These 13 patients
(homecare) accounted for 36% of all medical costs for Hepatitis C Virus members.    The
article goes into co-morbid costs associated with HIV, renal failure,
pneumonia, etc..     Rx claims for the total membership in treatment were
$1,495,096.  Only 60 of the individuals identified from the 395 were on
combination therapy (Rebatron) while 25 were on monotherapy.   Rx claims for
treatment of Hepatitis C Virus accounted for only $437,735 of the total $1,495,096.   The
vast majority of other Rx costs were associated with behavioral health
(depression), cardiovascular and respiratory medications.

 




Total healthcare and Rx claims for this MCO totaled $5.5 million for
1999.  By my calculations, the total PMPY costs for the MCO were $74 or
$6.16 PMPM.   The total Per Patient Per Year costs (PPPY) were approx.
$14,000 or $1,260 PPPM.     The conclusion of the article authored by Amy
Phillips, Pharm. D. at Abbott Labs was that..."as the number of persons with
Hepatitis C Virus is expected to increase, the overall cost of healthcare for these
patients is likely to be significant"!


Regards,

Kevin Mead